The application of proteomics to the discovery of biomarkers of diseases severity and prognosis in chronic liver disease
Chronic liver disease (CLD) is a major and growing healthcare burden but is asymptomatic until liver fibrosis is advanced. Antiviral therapy can cure 50% with chronic hepatitis C virus (HCV) infection. Accurate staging of fibrosis requires invasive liver biopsy; predicting response to antivirals pri...
| Main Author: | |
|---|---|
| Published: |
St George's, University of London
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568724 |